PRATI, Fabio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.657
AS - Asia 10.752
EU - Europa 10.018
SA - Sud America 1.468
AF - Africa 183
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 12
Totale 42.113
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.312
SG - Singapore 3.391
CN - Cina 3.077
IT - Italia 2.616
GB - Regno Unito 2.547
SE - Svezia 1.374
VN - Vietnam 1.301
HK - Hong Kong 1.166
BR - Brasile 1.108
DE - Germania 778
UA - Ucraina 519
RU - Federazione Russa 465
FR - Francia 435
FI - Finlandia 406
TR - Turchia 396
KR - Corea 359
IN - India 222
BG - Bulgaria 179
CA - Canada 165
NL - Olanda 158
BD - Bangladesh 143
MX - Messico 118
JP - Giappone 110
AR - Argentina 108
ID - Indonesia 102
IQ - Iraq 92
PL - Polonia 82
BE - Belgio 76
ES - Italia 76
IE - Irlanda 74
EC - Ecuador 61
CO - Colombia 54
ZA - Sudafrica 53
PK - Pakistan 49
LT - Lituania 44
RO - Romania 39
UZ - Uzbekistan 39
AE - Emirati Arabi Uniti 34
CL - Cile 34
CH - Svizzera 31
MA - Marocco 31
AT - Austria 30
PE - Perù 28
MY - Malesia 25
PH - Filippine 25
VE - Venezuela 25
JO - Giordania 23
SA - Arabia Saudita 21
AU - Australia 19
AZ - Azerbaigian 19
NP - Nepal 18
TH - Thailandia 18
TN - Tunisia 18
KZ - Kazakistan 17
KE - Kenya 16
PY - Paraguay 16
BO - Bolivia 15
IR - Iran 15
EE - Estonia 14
TW - Taiwan 14
UY - Uruguay 14
EG - Egitto 13
ET - Etiopia 13
JM - Giamaica 13
IL - Israele 12
DZ - Algeria 11
OM - Oman 11
CZ - Repubblica Ceca 9
MD - Moldavia 9
PT - Portogallo 9
HN - Honduras 8
LB - Libano 8
PA - Panama 8
AL - Albania 7
EU - Europa 7
QA - Qatar 7
BH - Bahrain 6
CR - Costa Rica 6
DO - Repubblica Dominicana 6
GR - Grecia 6
KG - Kirghizistan 6
PS - Palestinian Territory 6
SN - Senegal 6
CI - Costa d'Avorio 5
GT - Guatemala 5
HU - Ungheria 5
NI - Nicaragua 5
RS - Serbia 5
DK - Danimarca 4
KW - Kuwait 4
LA - Repubblica Popolare Democratica del Laos 4
SK - Slovacchia (Repubblica Slovacca) 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
GY - Guiana 3
ML - Mali 3
NO - Norvegia 3
SC - Seychelles 3
TT - Trinidad e Tobago 3
BA - Bosnia-Erzegovina 2
Totale 42.065
Salva come PNG Salva come JPEG
Città #
Singapore 2.094
Santa Clara 2.043
Ashburn 1.742
Southend 1.634
Chandler 1.384
Fairfield 1.360
Hefei 1.200
Woodbridge 1.164
Hong Kong 1.140
Jacksonville 955
Houston 851
Dearborn 737
Nyköping 687
Ann Arbor 676
San Jose 643
Beijing 529
Wilmington 521
Seattle 500
London 467
Cambridge 442
Ho Chi Minh City 388
Seoul 326
Hanoi 317
Los Angeles 308
Council Bluffs 294
Modena 269
The Dalles 263
Helsinki 237
Chicago 224
Des Moines 211
New York 203
Izmir 189
Princeton 188
Milan 179
Sofia 172
Dallas 169
Eugene 154
San Diego 153
Lauterbourg 143
Shanghai 134
São Paulo 115
Berlin 109
Buffalo 109
Redwood City 106
Moscow 95
Orem 92
Tokyo 73
Rome 72
Warsaw 70
Salt Lake City 69
Da Nang 63
Dublin 62
Fremont 62
Munich 60
Bologna 56
Brooklyn 55
Denver 55
Chennai 54
Reggio Emilia 53
Brussels 52
Jakarta 52
Frankfurt am Main 50
Atlanta 49
Phoenix 48
Bremen 46
Haiphong 46
Guangzhou 45
Montreal 44
Amsterdam 43
Kunming 42
Boardman 41
Kent 41
Mexico City 41
Yalova 41
Elk Grove Village 38
Tampa 38
Toronto 36
Parma 35
Tashkent 35
Columbus 34
Rio de Janeiro 33
Baghdad 32
Manchester 32
Falls Church 30
Florence 29
Johannesburg 29
Norwalk 27
Stockholm 27
Belo Horizonte 26
Miano 26
San Francisco 25
Boston 24
Nanjing 24
Hải Dương 23
Vancouver 23
Curitiba 22
Dhaka 22
Poplar 22
Quito 22
Redondo Beach 22
Totale 28.137
Salva come PNG Salva come JPEG
Nome #
Sintesi di alogenuri vinilici e gem-dialogenuri da aldeidi e chetoni 1.007
1,2,3-Triazolylmethaneboronate: A Structure Activity Relationship Study of a Class of β-Lactamase Inhibitors against Acinetobacter baumannii Cephalosporinase 818
A Mild Synthesis of Vinyl Halides and gem-Dihalides Using Triphenyl Phosphite–Halogen-based Reagents 429
Synthesis, activity and molecular modeling of a new series of chromones as low molecular weight protein tyrosine phosphatase inhibitors 387
Click Chemistry in Lead Optimization of Boronic Acids as β-Lactamase Inhibitors 386
Effetto del Bromuro di Allile e dell'Alcool Allilico nella Riduzione con Lievito di Composti Carbonilici alfa-Alogenati 383
Biocatalytic asymmetric synthesis of (S)- and (R)-Timolol 380
Chemo-enzymatic synthesis of levodropropizine 378
Isolation, structure elucidation and total synthesis of a cytotoxic dienone from Echinacea pallida 370
Deciphering the evolution of cephalosporin resistance to ceftolozane-tazobactam in pseudomonas aeruginosa 361
Sintesi di Nitrili da Ammidi: Degradazione di Von Braun in Condizioni Blande 356
Boronic acid transition state inhibitors active against KPC and other class a β-lactamases: Structure-activity relationships as a guide to inhibitor design 355
(S)-(+)-N-acetylphenylglycineboronic acid: A chiral derivatizing agent for Ee determination of 1,2-diols 345
(R)-(+) and (S)-(-) ethyl 4,4,4-trifluoro-3-hydroxy butanoate by enantioselective Baker's yeast reduction 342
A mild synthesis of nitriles by von Braun degradation of amides using triphenyl phosphite-halogen-based reagents 341
An Easy Route to Enantiomerically Enriched 7- and 8-Hydroxy-stearic Acids by Olefin-Metathesis-Based Approach 334
Biochemical and structural analysis of inhibitors targeting the ADC-7 cephalosporinase of Acinetobacter baumannii 328
Ligand-Induced Proton Transfer and Low-Barrier Hydrogen Bond Revealed by X-ray Crystallography 324
Acetamidomethaneboronic acids bearing the R1 side chains of beta-lactams as inhibitors of beta-lactamase enzymes 322
A novel approach to a precursor of the carbapenem antibiotic PS-5 via aziridine stereospecific carbonylation 318
Crystal structures of KPC-2 and SHV-1 β-lactamases in complex with the boronic acid transition state analog S02030 314
A very mild access to 3,4-dihydroisoquinolines using triphenyl phosphite-bromine-mediated Bischler-Napieralski-type cyclization 312
Inhibiting the β-Lactamase of Mycobacterium tuberculosis (Mtb) with Novel Boronic Acid Transition-State Inhibitors (BATSIs) 310
Boronic acid inhibitors of beta-lactamases as therapeutic agents in treatment of antibiotic-resistant infection diseases 309
Enzymatic Resolution of Chiral N-Alkyloxaziridine-3,3-dicarboxylic Esters 308
Chimica Organica 307
Alkene Metathesis in Organic Synthesis 303
Enantioselective total synthesis of (-)-microcarpalide 302
Sintesi Stereoselettiva di Acidi Boronici Inibitori di beta-Lattamasi 302
'Ligand-free-like' CuCl-catalyzed atom transfer radical cyclization of N-substituted N-allyl polychloroamides to γ-lactams. 302
Candida Cylindracea Lipase Catalysed Hydrolysis of Methyl Aziridine 2-Carboxylates and 2,3-Dicarboxylates. 300
Design, synthesis, crystal structures and antimicrobial activity of sulfonamide boronic acids as beta-lactamase inhibitors 298
Inhibition of Quorum Sensing-dependent biofilm formation and virulence factors in Pseudomonas aeruginosa by the boronic acid SM23 297
The β-Lactamase Inhibitor Boronic Acid Derivative SM23 as a New Anti-Pseudomonas aeruginosa Biofilm 295
Synthesis, characterization and metal coordination of a potential β-lactamase inhibitor: 5-Methyl-2-phenoxymethyl-3-H-imidazole-4-carboxylic acid (PIMA) 291
The triphenyl phosphite-chlorine reagent in the synthesis of pyrroles from N-allylamides 288
Biotransformations of Fluorinated Sulphenyl and Sulphonyl Compounds 288
Catalisi Enzimatica nella Sintesi di Prodotti Fluorurati Chirali 288
Partecipazione a Spin Off 288
A mild synthesis of nitriles by TPPX2-promoted dehydration of primary amides 288
Paternó-Büchi reaction versus hydrogen abstraction in the photochemical reactivity of alkenyl boronates with benzophenone 284
One-Pot Synthesis of Imidazole-4-Carboxylates by Microwave-Assisted1,5-Electrocyclization of Azavinyl Azomethine Ylides 282
Optimizing Cell Permeation of an Antibiotic Resistance Inhibitor for Improved Efficacy 282
Enantiomeric excess of 1,2-diols by formation of cyclic boronates: an improved method 281
Electron and electrospray ionization mass spectrometry in the characterization of some 1-allyl-3-phenylaziridines 275
Enzymatic Resolution of Aziridine-Carboxylates 275
Derivatives of Optically Active 1-Chloro-2,2-bismethoxycarbonylaziridine: Absolute Configuration and X-Ray Molecular Structure of (-)-(E)-1-Chloro-2- methoxycarbonyl- 2-methylcarbamoylaziridine. 275
Applications of the (PhO)(3)PCl2 reagent: A new protocol for mild cleavage of sulfinamides and sulfonamides 275
The β-lactamase Inhibitor Boronic Acid SM23 Inhibits Pseudomonas aeruginosa Biofilm Formation and Virulence Factor Production 274
alpha- and beta-Aminoacids from Optically-Active Aziridine-2-Carboxylates 273
Total synthesis of )-microcarpalide, a novel microfilament disrupting metabolite 272
Small-molecule inhibitors prevent the genotoxic and protumoural effects induced by colibactin-producing bacteria 272
Acido alfa-Acetammido-alfa-Fenilmetanboronico come Agente Derivatizzante Chirale per la Determinazione dell’Eccesso Enantiomerico di 1,2-Dioli 271
Chiroptical Properties of (S)-(-) Methyl Glycolate-d1 269
Biotrasformazioni di Composti Fluorurati 268
Total synthesis of a dienynone from Echinacea pallida 268
Enantioselective Synthesis of (S)-(Ð)-5,5,5-Trifluoro-4-Hydroxy-2-Pentanone by Baker's Yeast Reduction. 266
A Chemoenzymatic Approach to beta-Lactams from Hydroxymethyl Aziridines 262
A comprehensive and contemporary “snapshot” of β-lactamases in carbapenem resistant Acinetobacter baumannii 262
Synthesis of N-bridgehead fused bicyclic beta-lactams through organometal-mediated transformations of 1,2-dialkenylaziridines 260
Sulfonamido-substituted boronic acids as β-lactamase inhibitors for treatment of antibiotic-resistant bacterial infections 260
Negative Epistasis and Evolvability in TEM-1 β-Lactamase—The Thin Line between an Enzyme's Conformational Freedom and Disorder 258
Lipase-Catalyzed Resolution and Desymmetrization of 2-Hydroxymethylaziridines 256
Isolation, structure elucidation, synthesis and cytotoxic activity of polyacetylenes and polyenes from Echinacea pallida 253
α-Aminoester-Derived Imidazoles by 1,5-Electrocyclization of Azavinyl Azomethine Ylides 253
Design and exploration of novel boronic acid Inhibitors reveals important Interactions with a clavulanic acid-resistant sulfhydryl- variable (SHV) β‑ lactamase 253
Low-temperature deacylation of N-monosubstituted amides 252
Sintesi Stereospecifiche di beta-Lattami da Aziridine 252
Highly enantioselective reduction of ethyl 4-chloro-3-oxobutanoate to L-and D-3-hydroxyesters with baker`s yeast 251
Unexpected tricovalent binding mode of boronic acids within the active site of a penicillin binding protein 249
alpha- and beta-Aminoacids from Optically-Active Aziridine-2-Carboxylates 246
Novel Insights into the mode of inhibition of class A SHV-1 β-lactamase revealed by boronic acid transition state inhibitors 245
Chiroptical Properties of (S)-(-) Methyl Glycolate 244
Optically Active cis- and trans-1-Chloro-2-methoxycarbonyl-2-methylcarbamoyl-aziridines. Stereochemical Properties 244
Inhibition of Acinetobacter -Derived Cephalosporinase: Exploring the Carboxylate Recognition Site Using Novel β-Lactamase Inhibitors 243
Chimica Organica 242
Sintesi Asimmetrica Biocatalitica di (S)-(–)-Timolo 241
Isolation, structure elucidation, synthesis and cytotoxic activity of polyacetylenes and polyenes from Echinacea pallida 240
Straightforward synthesis of chiral non-racemic α-boryl isocyanides 240
Nanomolar inhibitors of AmpC beta-lactamase 239
Optically Active α-Phenylethylamine as Efficient Organocatalyst in the Solvent-free Reactions Between 2,3-Butanedione and Conjugated Nitroolefins 239
Exploring sequence requirements for C3/C4 carboxylate recognition in the Pseudomonas aeruginosa cephalosporinase: Insights into plasticity of the AmpC β-lactamase 237
An efficient and versatile synthesis of new Trojan-horse cephalosporins 235
High adaptability of the omega loop underlies the substrate-spectrum-extension evolution of a class A β-lactamase, PenL 235
Boronic Acid Transition State Inhibitors as Potent Inactivators of KPC and CTX-M β-Lactamases: Biochemical and Structural Analyses 234
Approcci sintetici alla 6-epi-decarestrictina C1 234
Fragment-guided Design of Subnanomolar β-Lactamase Inhibitors Active in vivo 233
Absolute Configuration of 1-Chloro-2,2-bismethoxycarbonylaziridine and Derivatives 233
Enzymatic Resolution of Aziridine- and Oxaziridine-Carboxylates 232
Aziridine Bicicliche con Azoto a Testa di Ponte: Sintesi, Espansione Carbonilativa a beta- Lattami Biciclici 230
Structural Studies of N-Chloroaziridinecarboxylates by Multinuclear NMR Spectroscopy 229
Enantioselective Lipase-Catalyzed Acetylation of beta-Lactams Precursors of Carbapenem Antibiotics 229
Structure-based approach for identification of novel phenylboronic acids as serine-β-lactamase inhibitors 229
A method of treating a bacterial infection in a subject in need thereof includes administering to the subject therapeutically effective amts. of at least one β-lactam antibiotic and at least one triazolylmethyl boronic acid β-lactamase inhibitor. 229
The β-lactamase Inhibitor Boronic Acid SM23 as a new anti-Pseudomonas aeruginosa Biofilm Compound 228
Characterization of 2-Phenylaziridine Derivatives: Tandem MS and MSn Experiments Under Electron Ionization and ESI Conditions 225
Stereochemistry of Nucleophilic Ring-Opening Reactions of Optically Active N-Acetyl-2-Methoxycarbonylaziridine 223
Synthesis of [(1,2,3-Triazol-1-yl)methyl]boronic Acids Through Click Chemistry: Easy Access to a Potential Scaffold for Protease Inhibitors 223
Optically Active N-Chloro-2,2-bismethoxycarbonylaziridine by Enzymatic Hydrolysis 222
The structures of Ceftazidime and Its Transition State Analog in Complex with AmpC-beta-lactamase: Implication for Resistance Mutation and Inhibitor Design 221
Totale 29.261
Salva come PNG Salva come JPEG
Categoria #
all - tutte 145.822
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 145.822
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021412 0 0 0 0 0 0 0 0 0 0 233 179
2021/20223.027 150 351 246 263 135 190 131 156 316 207 524 358
2022/20233.816 475 427 263 405 400 659 99 324 459 35 126 144
2023/20242.347 96 150 106 247 391 258 406 237 74 84 80 218
2024/20257.753 355 115 187 475 1.424 1.185 480 542 738 241 768 1.243
2025/202613.267 929 747 1.313 1.711 1.980 1.243 1.616 641 1.301 1.320 466 0
Totale 42.288